Withdrawal of Registration Statement (rw)
October 31 2018 - 2:08PM
Edgar (US Regulatory)
October
31, 2018
VIA EDGAR
Securities
and Exchange Commission
Division
of Corporation Finance
100 F
Street, N.E.
Washington,
D.C. 20549
Re
|
Sunshine Biopharma Inc.
Withdrawal of Registration Statement on Form S-1
Filed October 9, 2018
File No. 333-227748
|
Ladies
and Gentlemen:
Pursuant to Rule
477 promulgated under the Securities Act of 1933, as amended (the
“Securities Act”), Sunshine Biopharma Inc., a Colorado
corporation (the “Company”) hereby respectfully applies
for the withdrawal of the Company’s registration statement on
Form S-1 (File No. 333-227748), together with all exhibits and
amendments thereto, which was initially filed with the Securities
and Exchange Commission (the “Commission”) on October
9, 2018 (the “Registration Statement”).
The
Company requests the withdrawal of the Registration Statement
because it has determined not to pursue the contemplated offering
at this time. The Registration Statement has not been declared
effective by the Commission, and the Company confirms that no
securities were sold in connection with the offering described in
the Registration Statement.
Accordingly, the
Company hereby respectfully requests that the withdrawal of the
Registration Statement be effective as of the date hereof or the
earliest practicable date hereafter. The Company also requests, in
accordance with Rule 457(p) promulgated under the Securities Act,
that all fees paid to the Commission in connection with the filing
of the Registration Statement be credited for future use to the
Company’s account.
If you
have any further questions regarding this request for withdrawal,
or if you require any additional information, please contact Brian
R. Goldberg, Esq. at 732-395-4412.
|
Sunshine
Biopharma Inc.
|
|
|
|
|
|
|
By:
|
/s/ Dr. Steve Slilaty
|
|
|
|
Dr.
Steve Slilaty
Chief
Executive Officer
|
|
|
|
|
|
|
|
|
|
cc:
Brian R. Goldberg, Esq., Lucosky Brookman LLP